Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Blueprint Medicines Corporation | BPMC

Daily Technical Analysis of Blueprint Medicines Corporation

Blueprint Medicines bobbled around today only ended up 0.22% since yesterday.

Currently BPMC isn't at a clear support/resistance line that seems tradable. BPMC has been bouncing around but hasn't taken a very clear direction over the last few months. So it doesn't have very much obvious momentum in either direction. BPMC might find some support at the 59.29 level, buyers might push the price back up from here. But it's not very clear what will happen.


Last analyzed on 2024-11-13

Analyst Ratings for Blueprint Medicines By Price Target And Rating

The analysts feel fairly neutral on the prospects for Blueprint Medicines but a little more positive than negative. The current Analysts Sentiment Score is 33.25. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. On 2024-05-03 Barclays increased their price target by 7.14% to $75.00. Piper Sandler gave a boost to their price target and moved to $104.00 from $78.00 on 2024-05-03. Needham & Company LLC announced that they are reiterating a rating of Buy on 2024-05-02 and dropped their 1 year price target to $97.00 which is down from $97.00. On 2024-04-26 there was confirmation of the previous rating by Wedbush which was Outperform and they lowered their price target by 0% to $110.00 from a previous target of $110.00. On 2024-04-26 HC Wainwright reiterated their rating of Buy and added a price target of $125.00. On 2024-04-26 Stifel Nicolaus increased their price target by 8.33% to $130.00. JMP Securities reiterated a rating of Market Outperform on 2024-04-10 and added a price target of $114.00. On 2024-02-16 Citigroup increased their price target by 20.37% to $65.00. Raymond James gave a boost to their price target and moved to $100.00 from $85.00 on 2023-12-22. Wells Fargo & Company boosted their price targ by 33.72% to $115.00 on 2023-12-19.

Company Ratings Score ?
Composite analyst sentiment score
Positive Ratings Negative Ratings Boost Price Target Lower Price Target
BPMC33.2539.53-0.4727.89-0.45

Earnings Per Share (EPS) Estimates By Year and Quarter

(updated 2024-04-07)
Company YOY Growth Score (typical -20 to +20) Revision Directions (-6 to +6)
BPMC0.000.00

Short interest for Blueprint Medicines

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Company Short Score (typical 1-15) ?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
Short Interest Days to Cover Rate of Change Shares Short
BPMC7.34%7.235877.22.974390000

How Blueprint Medicines compares to the broader Healthcare sector and the more specific Biotechnology industry

Segment Count 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Analysts Ratings ?
Biotechnology

Show Me Companies With:

S-Momentum: Highest | Lowest
1 Day Growth: Highest | Lowest
5 Day Growth: Highest | Lowest
1 Month Growth: Highest | Lowest
6 Month Growth: Highest | Lowest
950.79-3.72-2.26-0.857.6740.0455.086.666.303.43-14013.76-12974.3016.844.749.368.41
Healthcare

Show Me Companies With:

S-Momentum: Highest | Lowest
1 Day Growth: Highest | Lowest
5 Day Growth: Highest | Lowest
1 Month Growth: Highest | Lowest
6 Month Growth: Highest | Lowest
2300.88-1.52-0.30-2.165.7227.6453.668.868.578.32-12704.99-11984.8218.914.246.745.55

Social Sentiment for Blueprint Medicines

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.

Ticker Social Sentiment(1-10)
BPMC

Companies with the highest correlation to Blueprint Medicines

Company Score 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Score
FOLD | Amicus Therapeutics, Inc0.980.74-4.96-18.45-14.451.27-10.8717-2.28-1.73-4.95-17716.03-1816.13009.67196
VCYT | Veracyte, Inc.0.880.135.8319.5923.9788.1055.687587.7754.0728.480.00-24528.4315004.97884
RNA | Avidity Biosciences, Inc.0.860.92-12.65-3.320.0558.90644.887365.8295.41178.200.00-33401.690011.8771
EDIT | Editas Medicine, Inc. Com0.84-2.82-13.00-24.21-34.51-58.66-76.1947-172.46-138.74-176.20-57394.912.090016.4101
PD | PagerDuty, Inc.0.830.80-3.885.13-3.19-3.83-11.3865-6.01-7.89-28.72170.07-3200.33100012.2696
NTLA | Intellia Therapeutics, In0.82-7.15-13.23-17.22-41.30-47.27-53.9061-82.93-57.08-57.19-41948.46-1911.170010.4627
MDGL | Madrigal Pharmaceuticals,0.80.934.7656.2126.4435.0268.27648.7410.727.700.00-23329.50125018.5824

Top 3 correlating companies

See full charts for all peers

Sentiment Score

How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.

Earnings Estimates
Analyst Rating
Price Targets
Short Interest
Financials
Options Sentiment
Institutional Ownership
Social Sentiment
Fidelity Summary
Overall Summary Notes
Calculated Sentiment Sum

Score Sum
(1-45)

/

Average
(1-5)

+

Pattern Rank
(1-5)

=

Total Score
(1-10)

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-